Skip to main content

brivaracetam (Briviact®)

 

Status: In progress

Adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in children from 2 years to < 4 years of age with epilepsy.

Medicine details

Medicine name brivaracetam (Briviact®)
Formulation 10 mg, 25 mg, 50 mg, 75 mg, 100 mg film-coated tablets; 10 mg/ml oral solution; 10 mg/ml solution for injection/infusion
Reference number 4614
Indication

As above

Company UCB Pharma Ltd
BNF chapter Central nervous system
Submission type Licence extension for paediatric use
Status In progress
AWMSG meeting date TBC
Date of issue TBC
Follow AWTTC: